Description
Juvelook Volume (also commercially recognized as Lenisna) is a high-density hybrid biostimulator designed for deep structural volumization, facial contour restoration, and deep tissue neocollagenesis. Combining Poly D,L-Lactic Acid (PDLLA) with non-crosslinked Hyaluronic Acid (HA) in a 200mg high-concentration matrix, it triggers intensive long-term collagen synthesis while providing immediate tissue hydration. Engineered with larger micro-particle dimensions than standard Juvelook (50mg), Juvelook Volume is optimized for deep subdermal placement, correction of severe volume loss, hollow temples, deep nasolabial folds, and body contouring.
Key Product Benefits
-
Deep Structural Neocollagenesis: High-concentration PDLLA stimulates long-term host fibroblast production of Type I collagen, restoring lost facial architecture.
-
Immediate Hydration & Volumization: Non-crosslinked Hyaluronic Acid provides instant fluid space-filling, eliminating the initial visual collapse common with standard PLA implants.
-
High Safety & Smooth Integration: Patented porous micro-spheres promote uniform cell ingrowth and gradual bio-resorption without nodule or granuloma formation.
-
Sustained Longevity: Results progressively build over 2–3 months and maintain structural integrity for up to 24 months.
-
Versatile Facial & Body Contouring: Excellent for facial lipoatrophy, deep structural folds, hip dips, and skin laxity on body areas.
Target Treatment Areas
-
Midface & Cheeks: Restoring malar volume and correcting sunken cheek contours.
-
Temples & Jawline: Rebuilding hollow temples, sculpting the mandible, and improving lower-face sagging.
-
Deep Facial Folds: Softening severe nasolabial folds and marionette lines.
-
Body Contouring & Tightening: Restoring volume to hip dips, gluteal depressions, and sagging skin on arms or knees.
Product Specifications
| Feature | Specification |
| Product Name | Juvelook Volume (Lenisna) PLA/HA Hybrid Filler |
| Active Composition | PDLLA (Poly D,L-Lactic Acid) 170mg + Hyaluronic Acid 30mg |
| Total Weight per Vial | 200mg / vial (Freeze-dried micro-spheres) |
| Formulation Type | High-Density Hybrid Biostimulator & Structural Volumizer |
| Packaging Layout | 1 Vial x 200mg per box |
| Reconstitution Volume | 5ml to 7ml Sterile Saline (0.9% NaCl) + optional 1ml Lidocaine |
| Injection Layer | Deep Subdermal / Periosteal / Subcutaneous (Cannula recommended) |
| Recommended Course | 2 to 3 sessions spaced 6 to 8 weeks apart |
| Storage Parameters | Store between 1°C to 30°C; protect from extreme heat, moisture, and direct light |
Primary Active Components
-
PDLLA (Poly D,L-Lactic Acid – 170mg): Larger spherical, porous microparticles engineered for deep tissue stimulation. Triggers a sustained biostimulatory response that builds dense collagen matrices over time.
-
Hyaluronic Acid (30mg): High-concentration HA base that acts as an immediate filler vehicle, smoothing particle flow and preventing micro-particle agglomeration.
Reconstitution & Application Protocols
-
Reconstitution Procedure: Add 5ml to 7ml of sterile 0.9% saline solution into the 200mg vial (with optional 1ml Lidocaine). Allow hydration for at least 30 to 60 minutes or use a mechanical vortex mixer prior to treatment.
-
Administration Method: Injected into the deep subdermal or pre-periosteal layer using a 18G–22G blunt cannula or fine needles (25G–27G) depending on the target anatomy.
-
Recommended Treatment Cycle: Perform 2 to 3 sessions spaced 6 to 8 weeks apart, with maintenance recommended after 18 to 24 months.
-
Post-Treatment Guidance: Perform post-procedure massage to ensure uniform particle dispersion. Advise patients to avoid heavy thermal exposure (saunas, sunbeds) and strenuous exercise for 5 to 7 days.
Frequently Asked Questions (FAQ)
Q: What is the primary difference between Juvelook (50mg) and Juvelook Volume (200mg)?
A: Juvelook (50mg) features smaller particles for superficial intradermal injection in delicate zones (under-eyes, fine lines). Juvelook Volume (200mg) features larger particles and higher concentration for deep subdermal placement, structural volume restoration, and deep fold correction.
Q: Is Juvelook Volume the same product as Lenisna?
A: Yes. Both represent VAIM’s 200mg PDLLA + HA formulation. “Juvelook Volume” and “Lenisna” are used interchangeably in global aesthetic distribution for the structural volumizing variant.
Q: Does Juvelook Volume carry a risk of nodules?
A: The spherical, highly porous structure of VAIM’s microparticles allows rapid tissue integration, drastically reducing the risk of granulomas compared to traditional sharp-angled PLLA formulations.
⚠️ Disclaimer & Intellectual Property Notice
Technical names, packaging parameters, and active ingredient specifications serve strictly for accurate product identification and descriptive purposes in professional aesthetic contexts.
